News

Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing
Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...
Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
Kenvue Inc. stock falls Tuesday, underperforms market
The stock's fall snapped a four-day winning streak.
Business Wire2d
Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...
Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood
The maker of Tylenol and Benadryl named director Kirk Perry as interim chief executive. Shares rallied over 5% before t ...
Barchart on MSN18h
Kenvue's Q2 2025 Earnings: What to Expect
Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a global consumer health company. Valued at $41.9 billion by market ...
6KVUE : Assessing Kenvue: Insights From 6 Financial Analysts
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...